Valiant Laboratories Limited

NSE VALIANTLAB.NS

Valiant Laboratories Limited Total Assets for the year ending March 31, 2024: USD 41.08 M

Valiant Laboratories Limited Total Assets is USD 41.08 M for the year ending March 31, 2024, a 58.56% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • Valiant Laboratories Limited Total Assets for the year ending March 31, 2023 was USD 25.91 M, a 8.21% change year over year.
  • Valiant Laboratories Limited Total Assets for the year ending March 31, 2022 was USD 23.94 M, a 64.92% change year over year.
  • Valiant Laboratories Limited Total Assets for the year ending March 31, 2021 was USD 14.52 M.
Key data
Date Total Assets Current Liabilities Total Non-Current Liabilities Shareholders' Equity
Market news
SV Wall Street
NSE: VALIANTLAB.NS

Valiant Laboratories Limited

CEO Mr. Santosh Shantilal Vora
IPO Date Oct. 6, 2023
Location India
Headquarters 104, Udyog Kshetra
Employees 77
Sector Industrials
Industries
Petrochemicals Chemicals & Advanced Materials Cleaning Supplies Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics
Description

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

StockViz Staff

February 2, 2025

Any question? Send us an email